Illinois SB3323 introduced to exclude specified drugs from the PMP and require purging testosterone PMP records by Jan 1, 2027

Illinois SB3323 (104th General Assembly) was introduced to amend 720 ILCS 570/316 and add new 720 ILCS 570/316.2. As described in the research text, the bill would provide that the Illinois Prescription Monitoring Program does not apply to specified drugs (testosterone, mifepristone, misoprostol, GnRH analogues, estrogen). It would also require the Illinois Department of Human Services to purge existing PMP records concerning testosterone by January 1, 2027 and adopt/update implementing rules by January 1, 2027. Compliance impact: could change PMP reporting/recordkeeping scope for dispensers and PMP system operators, and require data retention/deletion processes tied to testosterone records.